GlassScriptPhysician profile
Alex M Gerber
NPI 1114156841
$14,622.69
in general payments reported to CMS, 2019-2025
22 companies · $7,828 in 2025
The $7,828 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $332 · 2021: $544 · 2022: $1,280 · 2023: $1,398 · 2024: $2,778 · 2025: $7,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,175 · Food and Beverage: $4,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,175.00 |
| Food and Beverage | $4,828.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $8,193.99 | 2024-2025 | Idose, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $1,283.95 | 2019-2025 | Cequa |
| Alcon Vision LLC | $895.70 | 2019-2025 | Rocklatan, Rhopressa, Tryptyr |
| Abbvie INC. | $804.15 | 2022-2025 | |
| Biotissue Holdings INC. | $556.18 | 2023-2024 | |
| Sight Sciences, INC. | $555.11 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $454.99 | 2020-2022 | |
| Lensar, INC. | $293.20 | 2024-2025 | Lensar Laser System |
| Bausch & Lomb Americas INC. | $246.50 | 2022-2024 | Envista Mx60 Iol, Stellaris, Xiidra |
| Kala Pharmaceuticals, INC. | $195.38 | 2019-2021 | |
| Ocular Therapeutix, INC. | $191.65 | 2023-2025 | Dextenza |
| Oyster Point Pharma, INC. | $174.71 | 2023-2024 | Tyrvaya, Ryzumvi |
| New World Medical,INC. | $170.10 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Johnson & Johnson Surgical Vision, INC. | $113.52 | 2024 | Tecnis Iol, Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $108.09 | 2019-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $106.94 | 2022-2025 | Omidria, Rayone Emv, Rayone Spheric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $103.15 | 2019-2021 | |
| Shire North American Group INC | $64.80 | 2019 | |
| Coopervision INC. | $49.32 | 2025 | Myday Contact Lens, Clariti Contact Lens |
| Zogenix INC. | $22.33 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $19.68 | 2024 | Xdemvy |
| Harrow Eye, LLC | $19.25 | 2024 | Ilevro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.